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ABSTRACT 
 The use of short tandem repeats (STRs) for genotyping forensic case samples has 
long been an effective tool for human identification.  However, interpretation of forensic 
STR mixture samples can be difficult and any additional information to aid in this 
process can be invaluable.  Allele overlap and stutter during PCR can cause drop out of 
the minor contributor’s alleles and result in incorrect allele calling.  The Scientific 
Working Group on DNA Analysis Methods (SWGDAM) provides a list of guidelines on 
how to interpret DNA typing results from forensic STRs and mixtures, but there is still a 
significant variation in the interpretation of mixture samples between analysts in the same 
laboratory and between laboratories.  The Illumina MiSeq Forensic GenomicsTM system 
(Illumina Inc., San Diego, CA) is a massively parallel sequencing instrument that was 
developed specifically for the use in forensic DNA typing and which could provide 
sequence variations among on mixture samples.  The ForenSeqTM DNA Signature Prep 
Kit is a kit that can be used with the MiSeq FGxTM platform. The DNA Primer Mix A 
(DPMA) included in the ForenSeqTM kit targets 27 autosomal STRs, 24 Y-STRs, 7 X-
STRs and 94 identity single nucleotide polymorphisms (SNPs) on up to 32 or 96 samples, 
depending on the flow cell used.  This study compares the STR performance on DNA 
mixtures of the MiSeq FGxTM and CE and evaluates its reliability and robustness. 
vi 
The MiSeq FGxTM provides data in read count and the CE in relative fluorescence 
units (RFU), so the two output data cannot be directly compared to one another.  Instead, 
the ratio of two contributors was calculated at three mixture ratios (1:1, 1:4, and 1:9) to 
use as a mean of comparison.  The mean contributor ratios calculated on the MiSeq 
FGxTM were 1.799, 7.595, and 13.524 for the 1:1, 1:4, and 1:9 mixtures, respectively.  
This was not significantly different from the CE mean contributor ratios of 1.818, 7.722, 
and 14.827, respectively.  More allele dropouts occurred on the MiSeq FGxTM than the 
CE at both 1:4 and 1:9 mixture ratios, but sequencing provided the detection of six 
isoalleles based on sequence variants that could not be discerned by CE.  Other studies 
have shown full profile generation at these ratios, indicating there could have been some 
issues during library preparation.  Further studies should be performed to thoroughly 
validate the ForenSeqTM process and evaluate the sensitivity of the instrument.  Until 
then, it is recommended that the ForenSeqTM kit and MiSeq FGxTM system be used at 
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1.  INTRODUCTION 
1.1 Forensic DNA Analysis 
The use of human deoxyribonucleic acid (DNA) as an identification tool has 
produced a profound change in how criminal investigations are carried out.  Its ability to 
identify one individual out of the entire population quickly earned DNA profiling the status 
of “gold standard” [1] in the criminal justice system.  Since its discovery by Sir Alec 
Jeffreys in 1985 [2], significant advancements in the forensic DNA analysis methods have 
been made to improve its sensitivity, reproducibility, and discriminatory power [3].  Early 
analysis methods used restriction fragment length polymorphisms (RFLPs) or variable 
number tandem repeats (VNTRs), which were subsequently phased out in the 1990s by the 
current mainstream method of genotyping short tandem repeats (STRs) [4].  Since this 
transition, the pace of change has slowed in the advancement of incorporating new 
technologies.  However, in recent years, the use of what is known as massively parallel 
sequencing (MPS), or next generation sequencing (NGS), has emerged as an alternative 
technology in forensic DNA profiling [4]. 
1.2 What is DNA? 
 DNA is a long chain, highly negatively charged molecule that is located in nucleus 
of  most cells of the human body in the form of a double helix [5].  Each strand of the DNA 
molecule is made up of a chain of units known as nucleotides, which consist of a phosphate-
deoxyribose sugar backbone and one of four bases: adenine, guanine, cytosine, and 
thymine.  The bases of the two strands join together in pairs, where a base from one strand 
bonds via hydrogen-bonding to its complimentary base from the other strand.  The only 
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pairs possible are cytosine to guanine and thymine to adenine, making the two strands 
complimentary to each other [5].  This means that if the order of bases for one strand were 
known, the order for the other strand could be deduced because of the presence base 
pairing.  It is the order of these bases that makes up the genetic code responsible for creating 
and maintaining an organism.   
 In human somatic cells, DNA is subjected to an organized folding consisting of 
several levels of compaction using proteins known as histones.  One single strand of highly 
compacted double-stranded DNA is known as a chromatid, and there are 2 chromatids (or 
1 pair of chromatids) in a cell which make up one chromosome [6].  An individual has 23 
pairs of chromosomes, inheriting one chromosome from their mother and one chromosome 
from their father.  In eukaryotic DNA, much of the DNA is not translated to genes, and 
some of these non-translated regions consist of highly repetitive sequences of DNA [6].  It 
is the combination of these highly repetitive regions and the principles of Mendelian 
genetics that makes STR profiling possible. 
1.3 DNA Profiling Methods 
 All current DNA-typing methods rely on the same revolutionary technique, the 
polymerase chain reaction (PCR).  With its ability to create millions of copies of multiple, 
specific DNA regions at once in just a few hours, PCR has revolutionized the forensic DNA 
world since its discovery in 1985 [7].  In tandem with capillary electrophoresis (CE), 
forensic DNA profiling took a massive leap forward. 
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1.3.1 Short Tandem Repeats 
 STR sequences are regions of DNA that are shorter in length (~100-400 bp) than 
their VNTR predecessor (~400-1000 base pairs) and consist of a variable number of 
tandemly repeated sequences.  In forensic DNA-typing, the typical STR loci contain 
tetranucleotide repeats, or a four base pair (bp) sequence that is repeated a certain number 
of times [7].  Due to their high level of polymorphism and because of their short length, 
they are easily amplified with the PCR process [8].  The shorter length is advantageous for 
forensic samples because they are often degraded.  Where longer stretches of DNA would 
be broken up into smaller pieces, the shorter STR regions are more likely to be intact.  In 
1994, the use of STRs in conjunction with mitochondrial DNA sequencing on degraded 
DNA was demonstrated by analyzing 70 year-old bones to identify the remains of the 
Romanov family [9]. 
 PCR plays an important role in forensic DNA-typing because the primers used to 
locate and amplify the target STR regions can be modified with different fluorescent tags.  
This allows for many STR markers to be multiplexed together and still be resolved from 
each other by electrophoretic separation.  One of the first STR multiplexes in the early 
1990s  comprised of only four loci with a matching probability of 1 in 10,000, and by 1997, 
13 core STR loci were identified with a matching probability of more than one in a trillion 
unrelated individuals [7].  The scientific community has continued to improve these STR 
multiplex kits, with some of the latest kits containing up to 24 loci.   
 Individuals are identified based on the number of repeats at a specific locus, which 
can be determined by comparing the length of the DNA segment to an allelic ladder.  For 
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example, an individual with a 9 allele at the TPOX locus has a four-base unit repeated nine 
times and will be 4 bp longer than someone with an 8 allele, or 8 repeats. These repeats 
may be different in DNA sequence but identical in repeat length. CE analysis does not 
allow the determination of the sequence of the repeats while MPS can. This sequencing 
adds information beyond the length of the allele.  
1.3.2 Sanger Sequencing 
 Sanger sequencing was first described in 1977 with a methodology that uses some 
of the same mechanics as PCR.  It relies on DNA polymerase in the presence of a DNA 
template and the DNA building blocks, deoxyribose nucleotide triphosphates (dNTPs), to 
build a new strand of DNA.  However, it also utilizes dideoxyribose nucleotide 
triphosphates (ddNTPs) to terminate the DNA extension wherever they are incorporated 
because these do not contain a 3’-hydroxyl group [10] and, hence cannot form the 
phosphodiester bond necessary for chain extension.  Four reaction mixtures are set up 
containing all the dNTPs and each reaction mix receiving a different ddNTP: ddATP, 
ddGTP, ddTTP, or ddCTP.  When the template DNA is incubated in the presence of a 
polymerase and a mixture of, for instance, a ddATP and dNTPs, a mixture of different 
fragment lengths will be obtained based on whether a dNTP or the ddNTP is added at the 
location.  This occurs in each reaction, and when the 4 reactions are separated by gel 
electrophoresis in parallel, the bands will indicate where in the DNA sequence each ddNTP 
is added. 
 The Sanger method was widely used for short DNA regions of 500 to 700 bp [11], 
but larger regions of DNA posed a problem. The main limitation with Sanger sequencing 
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was the time required to create the fragments for sequencing by cloning into the 
bacteriophage lambda.  This is highlighted by the Human Genome Project, where it took 
multicenter collaborations more than 10 years to sequence 5% of the human genome using 
Sanger sequencing, with the last 95% of the genome sequenced in a year by incorporation 
of a new shotgun sequencing approach [11,12]. 
1.3.2.1 Mitochondrial DNA Testing 
 Sometimes in forensic science, conventional STR typing does not work if the 
sample is very old or degraded.  In these cases, mitochondrial DNA (mtDNA) testing can 
be used.  While nuclear DNA testing is more valuable and discriminatory, there are 
hundreds of copies of mtDNA in each cell compared to two copies of nuclear DNA, making 
it more likely to survive degradation.  However, the mtDNA genome is only 16,569 bp 
long and has only one region that has many bases not coding for a gene, known as the 
control region, or D-loop, that is 1,122 bp [7].  Because it is such a short region and not 
highly variable, typical STR-type analysis is not viable. Testing of mtDNA first introduced 
forensic DNA analysis to DNA sequencing.   
The first human mtDNA was sequenced in 1981 [13] with Sanger sequencing and 
became the reference sequence to which new sequences were compared.  This early 
identification of the mtDNA sequence allowed for PCR primers to be developed for the D-
loop, removing the long process of fragment cloning from the procedure.  Sequencing is 
carried out using four different fluorescent dyes attached to the four different ddNTPs and 
separation occurs using capillary electrophoresis (CE). As the DNA passes through the 
capillary, the different lengths of DNA fragments are separated by size, with each fragment 
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fluorescing the color of the ddNTP that was incorporated as the terminating base.  The 
order in which the fluorescing dyes are read by the CE indicates the DNA sequence. 
Mitochondrial DNA is inherited only from the maternal lineage, with all siblings 
and maternal relatives having identical mtDNA sequences [7].  Mass disaster or missing 
person cases can benefit from this type of testing for familial linkages but matches in 
forensic cases will be less significant.  While having another method for individualization 
when traditional methods are unavailable would be very helpful, mtDNA cannot be used 
alone for identification.  While effective for forensic mtDNA testing, CE-based Sanger 
sequencing does not have the resolution, speed, or throughput that is required to sequence 
the STRs currently used by forensic labs.  New technologies have been introduced to allow 
for the sequencing of multiple human genomes in a single run, known as second-generation 
sequencing (SGS) [12].   
1.3.3 Next Generation Sequencing 
 SGS, also known as next generation sequencing (NGS), has effectively overcome 
all the limitations that faced Sanger sequencing.  Higher throughput, increased resolution, 
and speed has made NGS a cheaper and more effective alternative to Sanger sequencing.  
One method in particular, sequencing-by-synthesis (SBS), has become widely adopted in 
areas of research ranging from microbial communities [14] to human virus and cancer 
research [15,16].  What distinguishes SBS from Sanger sequencing is the use of 
fluorescently labeled, reversible terminator dNTPs [17].  The bases are identified based on 
their fluorescence after addition, followed by the removal of the terminating portion which 
allows the addition of another reversible terminator dNTP.  This is more advantageous than 
7 
 
Sanger sequencing because it allows all the terminator dNTPs to be added simultaneously, 
instead of in separate tubes, improving accuracy and time and reducing the cost per sample.  
With the SBS method, it has been possible to sequence a whole human genome in a matter 
of 8 weeks [17] compared to the 10 years it took using Sanger sequencing. 
1.4 Difficulties in Forensic Analysis of Mixture Samples 
 Using currently available STR tests, single source samples are relatively 
straightforward to interpret, but with each additional contributor, the difficulty of 
interpreting a sample increases exponentially [18].  Forensic case samples can come in any 
number of contributors, and with the high regard that DNA is held at in the courtroom, it 
is important that these samples are interpreted accurately. One of the most prevalent 
forensic case types are sexual assault cases, where the samples often contain DNA from 
two or more individuals.  The Scientific Working Group on DNA Analysis Methods 
(SWGDAM) provides a list of guidelines on how to interpret DNA typing results from 
forensic STRs and mixtures [19], but there is still significant difference in the interpretation 
of mixture samples between laboratories and between individual analysts in the same 
laboratory [20,21]. 
 The large variation in mixture interpretation between labs and individuals has 
sparked the development of computational models for mixture interpretation, known as 
probabilistic genotyping.  Different software, such as STRmix, EuroForMix, and Lab 
Retriever, have been tested and validated for use in forensic cases [22–24].  
With the advancement of DNA-typing methods, new forensic kits can detect 
smaller and smaller amounts of DNA, increasing the likelihood of individuals being 
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detected.  Current STR kits are so sensitive that they have been able to obtain complete 
profiles from as little as 100 picograms (pg) of template DNA, and some studies have 
shown to be able to obtain profiles with as little as a single diploid cell [25].  As template 
level decreases, an inherent issue with PCR known as stutter becomes more of a problem, 
even with a single-source profile.  Other issues, such as preferential amplification of alleles 
and allele overlap (sharing) add to the difficulty of mixture interpretation. 
1.4.1 Stutter 
  STR analysis by PCR has revolutionized the forensic field, but it has its limits.  A 
common artifact of PCR occurs when the DNA polymerase skips, or sometimes repeats, 
one of the repeat motifs of the template DNA [26].  As the reaction continues, these strands 
of DNA then continue to be copied like the template strand and can be in high enough 
concentrations to be read by the CE.  They typically show up in a DNA profile as a peak 
one repeat (4 bp) shorter or longer than the parent allele and typically at a much lower peak 
height [27].  While it is usually easy to detect stutter in a single-source sample because of 
the peak height difference, it can be difficult to discern a stutter peak from a peak 
legitimately from a minor contributor, especially at low concentrations of the minor 
contributor.   
1.4.2 Allele Overlap 
 While forensic STR typing is a very powerful identification tool, mixture samples 
can be difficult to interpret if neither individuals profile can be assumed to be present in 
the mixture. STRs can only be separated by length, and when two individuals share the 
same allele at a locus, it is impossible to know if they share that allele or not using CE 
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analysis.  If a 2-person mixture has 3 alleles at a locus, the total number of possible allele 
combinations is 6.  One individual could be homozygous for one of those alleles and the 
other individual heterozygous with the other 2 alleles.  Or, they could both be heterozygous 
sharing one of the 3 alleles.  With the addition of a third person, the number of 
combinations for a 3 allele locus jumps from 6 to 29 [18].  When concentrations of one of 
the contributors falls to a low enough level, stutter peaks and minor contributor’s alleles 
can have similar peak heights.  Stutter has been known to range from 5% to 30% of the 
height of the parent allele [27], which can make determining if the minor contributor has 
an allele in the stutter position difficult. 
1.4.3 Preferential Amplification 
 Sometimes the ratio between allele peak heights can be used 2 contributor mixture 
analysis to deduce contributor genotypes.  SWGDAM recommends a peak height ratio 
>60% as a measure for two alleles (sister alleles) coming from the same individual [19].  
This is because of another inherent issue with PCR which is greater amplification of a locus 
relative to another.  This can result in large peak height differences between two alleles of 
one individual in a single source sample that may drop below the 60% cutoff 
recommendation (Figure 1).  If this occurs in a mixture sample and one relies solely on the 




Figure 1: Visual depiction of peak height imbalance in a STR profile 
1.5 The MiSeq Forensic Genomics System 
 To be able to produce a forensic STR profile and to know the sequence of those 
STRs could prove incredibly useful in identifying one contributor in a mixture.  One system 
looking to break out in the forensic field is the MiSeq Forensic Genomics System (FGxTM). 
The MiSeq FGxTM is a massively parallel sequencing (MPS) platform that 
sequences all of the currently mandated forensic STR loci as well as single nucleotide 
polymorphism (SNP) loci simultaneously using SBS chemistry.  The system uses the 
Verogen ForenSeqTM DNA Signature Prep Kit (Verogen, Inc., San Diego, CA), which 
comes with 2 different primer mixes: DNA Primer Mix A (DPMA) and DNA Primer Mix 
B (DPMB).  DPMA identifies 27 autosomal STRs, 24 Y-STRs, 7 X-STRs and 94 identity 
SNPs.  DPMB can identify everything from DPMA in addition to 56 ancestry informative 
SNPs and 24 phenotypic SNPs [28].  Additionally, the MiSeq FGxTM system utilizes one 
of two flow cells that can sequence up to 32 or 96 samples.   
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1.5.1 Improving mixture resolution with the MiSeq FGxTM 
 The clearest advantage that the MiSeq FGxTM has over conventional STR-based 
CE mixture analysis is that it can determine the specific DNA sequence at the forensically 
relevant STR loci. This makes it possible for alleles of the same length at a locus to be 
identified as two different alleles based on differences their sequence, or isoalleles.  This 
can not only separate 2 people from an apparent single allele but adding sequence variation 
to the already determined allele frequencies can also increase the power of discrimination.  
On top of being able to identify isoalleles, the sequencing data may also aid in the detection 
of the minor contributor’s alleles when they coincide with the stutter position of the major 
contributor’s alleles. 
1.6 Aim of this Study 
 Deconvolution of forensic STR mixture samples can be difficult and being able to 
obtain additional information to aid in this process will be important.  Compared to 
traditional CE-based STR analysis, the MiSeq FGxTM not only targets an additional 6 
autosomal STRs, 24 Y-STRs, 7 X-STRs and 94 SNPs on up to 96 samples at one time, it 
also provides the DNA sequence of those targets.  The additional loci as well as separation 
of alleles by sequence should provide much more information for resolving mixture 
samples.  The contributor ratio accuracy and MiSeq FGxTM performance is analyzed here 
and compared to current CE-based methods.  The DNA sequencing process used here 
requires 3 PCR amplification steps overall, which could increase the likelihood of 
preferential amplification.  Additionally, there are many wash steps and transfer steps 
involved in the purification and normalization of the libraries prior to sequencing, which 
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may increase profile variability. A side by side assessment of the ForenSeqTM Signature 
Prep Kit with the MiSeq FGxTM system and the GlobalFilerTM PCR Amplification Kit 
(Applied Biosystems, Foster City, CA) using equivalent samples containing two person 




2.  Materials and Methods 
DNA Quantitation was performed in a 7500 Real-Time PCR (RT-PCR) Instrument 
(Applied Biosystems, Foster City, CA) using Quantifiler Duo Kits (Applied Biosystems, 
Foster City, CA) according to the manufacturer’s specifications using 2 microliters (µL) of 
sample.  DNA concentrations were then calculated using a previously calibrated standard 
curve [29]. 
2.1 Sample Preparation 
 DNA samples were obtained as saliva samples collected anonymously from 7 
individuals.   The samples were washed prior to DNA extraction by mixing 300 
microliters (µL) of laboratory prepared TE Buffer and 300 µL of neat saliva.  Cells were 
pelleted by centrifugation at 3000 rotations per minute (rpm) for five minutes.   The 
supernatant was removed, the pellet was resuspended in 400 µL TE Buffer, and 
centrifuged again at 3000 rpm for five minutes.  This step was repeated, and the pellet 
was resuspended in 50 µL of TE Buffer. 
Nuclear DNA was extracted from each of the samples using the QIAmp DNA 
Investigator Kit (QIAGEN, Hilden, Germany) according to the QIAmp DNA Investigator 
Handbook Protocol “Isolation of Total DNA from Small Volumes of Blood or Saliva” 
[30] using 100 µL of saliva and an incubation at 56°C for 1 hour instead of the 
recommended 10 minutes.  The sample DNA was then stored at -20°C until further use. 
2.2 Amplification and Fragment Separation 
 DNA amplifications were performed using GlobalFilerTM PCR Amplification Kit 
in a GeneAmp® PCR System 9700 thermal cycler (Applied Biosystems, Foster City, CA) 
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with an initial amount of 0.5 ng of input DNA.  Each run contained a positive control using 
5 µL DNA Control 007 and a negative control that should not contain DNA.  Amplification 
was carried out with the following cycling parameters: 95°C for 1 minute, then a cycle of 
94°C for 10 seconds and 59°C for 90 seconds for 30 cycles, followed by a hold at 60°C for 
10 minutes and then 4°C indefinitely. 
After amplification, 1 µL of the amplified samples were added to the appropriate 
wells of a 96-well reaction plate.  Each well that received a sample contained 9.5 µL of 
HiDi deionized formamide and 0.5 µL of 600 LIZ® Size Standard.  The samples were then 
denatured by heating them at 95°C for 3 minutes and then chilled for 3 minutes.  Fragment 
separation was carried out using an ABI 3130 Genetic Analyzer Capillary Electrophoresis 
instrument (Applied Biosystems, Foster City, CA) using POP-4™ Polymer (Applied 
Biosystems, Foster City, CA) for separation with a 1.2 kilovolt (kV) injection for 2 
seconds.  Electropherograms (EPGs) were analyzed using GeneMapper® ID-X version 1.4 
with the stutter filter on and an analytical threshold set at 30 relative fluorescence units 
(RFU). 
2.3 Sample Selection 
To determine which samples would be used for mixture analysis, each sample 
was diluted down to 0.2 ng/µL, amplified with a target of 0.5 ng, and separated via CE.  
Each individual’s EPG was analyzed to confirm there was no contamination and then 
compared against each other EPG to identify the number of overlapping alleles.  The 
samples chosen were to have high heterozygosity with the highest amount of allele 
overlap to get the best chance for DNA sequence variation of overlapping alleles. 
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2.4 Mixture Preparation 
 The two samples selected with the most allele overlap were quantified in triplicate 
and then made into 3 mixture ratios: 1:1, 1:4, and 1:9.  Each mixture was made to a final 
volume of 100 µL at a concentration of 0.2 ng/µL, using TE Buffer if necessary. Each 
mixture was then amplified in quadruplicate over 2 runs following the chart in Figure 2 
using either GlobalFilerTM (as described above) or the ForenSeqTM DNA Signature Prep 
kit (as described in section 2.3). 
 
Figure 2: Flowchart illustrating the experimental set-up of both runs for each mixture. 
2.5 ForenSeqTM DNA Library Preparation 
 Before the mixture samples were processed for sequencing on the MiSeq FGxTM 
instrument (Illumina Inc., San Diego, CA), the samples must go through a 2-step PCR 
amplification process to amplify target loci and to add the necessary indexes (i5 and i7).  
Each sample is then purified through a series of wash steps, normalized to ensure samples 
of varying concentrations are represented equally, and eventually pooled and denatured for 
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sequencing.  Library preparation was conducted using the ForenSeqTM DNA Signature 
Prep Kit. 
2.5.1 Amplification and Target Tagging 
 Using a 96-well reaction plate labeled ForenSeq Sample Plate (FSP), 10 µL of a 
master mix (containing 4.7 µL PCR1, 0.3 µL enzyme mix, and 5.0 µL of DNA Primer Mix 
A [DPMA] per sample) was added to each well that would contain a sample.  5.0 µL of 
each sample, diluted down to 0.2 ng/µL, was added to the appropriate wells so that 1 ng of 
total DNA was in each well.  5.0 µL of 2800M control DNA (single-source human male 
genomic DNA) was used as a positive control and 5.0 µL of nuclease-free water as a 
negative control.  The plate was sealed and centrifuged at 1000 x g for 30 seconds and 
placed in the thermal cycler for amplification of target loci as follows: initial incubation at 
98°C for 3 minutes, 8 cycles of [45 seconds at 96°C, 30 seconds at 80°C, 2 minutes at 54°C, 
2 minutes at 68°C], 10 cycles of [30 seconds at 96°C, 3 minutes at 68°C], a final extension 
at 68°C for 10 minutes, and an infinite hold at 10°C. 
2.5.2 Target Enrichment 
 DNA is further amplified in this step along with the addition of Index 1 (i7) and 
Index 2 (i5) adapters that are required for cluster amplification and sample separation 
downstream.  There are 12 i7 adapters (701-712) which correspond to one column of a 96-
well plate (1-12) and 8 i5 adapters (501-508) which correspond to one row of a 96-well 
plate (A-H).  Using a multichannel pipette, 4 µL of each i7 adapter was added to the 
corresponding column and 4 µL of each i5 adapter was added to the corresponding row.  A 
total of 27 µL of PCR2 solution was then added to each well, followed by centrifugation 
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at 1000 x g for 30 seconds.  PCR was then performed as follows: initial incubation for 30 
seconds at 98°C, 15 cycles of [98°C for 20 seconds, 66°C for 30 seconds, 68°C for 90 
seconds], a final extension at 68°C for 10 minutes, and an infinite hold at 10°C. 
2.5.3 Library Purification 
 Samples are purified using Sample Purification Beads (SPB) to bind the DNA while 
the other reaction components are washed away.  45 µL of SPB are added to each well of 
a midi plate labeled Purification Bead Plate (PBP).  45 µL of each sample of the FSP was 
transferred to the corresponding well of the PBP, the plate was sealed, and left to shake at 
1800 rpm for 2 minutes.  The PBP plate was placed on a magnetic stand, the supernatant 
removed and discarded from each well, and then washed two times with freshly prepared 
80% ethanol, removing the supernatant each time.  To ensure all the ethanol was removed, 
the PBP plate was centrifuged at 1000 x g for 30 seconds, placed back on the magnetic 
stand, and then any residual ethanol was removed.  The plate was removed from the 
magnetic stand and the beads were resuspended in 52.5 µL of Resuspension Buffer (RSB) 
by shaking at 1800 rpm for 2 minutes.  The plate was then placed back on the magnetic 
stand and the solution was left until it cleared before 50 µL of each well was transferred to 
the corresponding well of a new 96-well PCR plate labeled Purified Library Plate (PLP). 
2.5.4 Library Normalization and Pooling 
 To a new 96-well midi plate labeled Normalization Working Plate (NWP), 45 µL 
of a master mix, made up of 46.8 µL Library Normalization Additives 1 (LNA1) per sample 
and 8.5 µL Library Normalization Beads 1 (LNB1) per sample, was transferred to each 
well that will contain a library.  20 µL from each well of the PLP were transferred to the 
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corresponding well of the NWP, the NWP was sealed and shaken for 30 minutes at 1800 
rpm.  After shaking, the NWP was placed on a magnetic stand and left until the liquid 
cleared before removing the supernatant of each well.  The NWP was then removed from 
the magnetic stand and washed twice as follows: 45 µL Library Normalization Wash 1 
(LNW1) was added to each well, the plate was sealed and shaken for 5 minutes at 1800 
rpm, placed back on the magnetic stand, and all of the supernatant from each well was 
removed.  The plate was then centrifuged for 30 seconds at 1000 x g, placed back on the 
magnetic stand, and any residual supernatant was removed from each well.  A solution of 
2N sodium hydroxide (HP3) was diluted down to 0.1N and 32 µL was added to each well 
before shaking for 5 minutes at 1800 rpm to resuspend the beads.  The plate was placed 
back on the magnetic stand until the solution cleared before 30 µL of each well was 
transferred to the corresponding well of a new 96-well reaction plate labeled Normalization 
Library Plate (NLP).   
2.5.5 Pooling and Denaturing the Libraries 
 To pool the libraries, 5 µL of each well of the NLP was transferred to a 1.5 mL 
microcentrifuge tube. 7 µL of this library pool was then transferred to a new tube 
containing 591 µL Hybridization Buffer (HT1) and 2 µL Human Sequencing Control 
(HSC) mixture (2 µL HSC, 2 µL HP3, and 36 µL water).  The tube was then heated at 96°C 
for 2 minutes for denaturation, inverted several times, and immediately placed in an ice-
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water bath for 5 minutes before loading the full volume into the MiSeq FGxTM Reagent 
Cartridge for sequencing.   
2.6 MiSeq FGxTM Sequencing 
 DNA sequencing was carried out on the MiSeq FGxTM instrument using the 
forensic genomics run type and micro flow cell, which allows for a maximum of 32 single-
source samples using DPMA, or 12 mixture/case samples.  Each run consisted of 12 pooled 
mixture libraries (four 1:1, four 1:4, and four 1:9) as well as the positive and negative 
controls for a total of 14 libraries per run.  There are 398 total sequencing cycles (each 
sequencing cycle reads one nucleotide base) consisting of 4 reads: Read 1, Index 1, Index 
2, and Read 2.  Read 1 is 351 cycles that sequences the first 351 bases in each of the forensic 
STR and SNP amplicons.  Index 1 and Index 2 are both 8 cycle reads that sequences the i7 
index and i5 index, respectively, for sample determination.  Lastly, Read 2 sequences the 
last 31 nucleotides of the amplicons in the reverse direction of Read 1 to aid in sequence 
alignment and to sequence any amplicons longer that 351 bp. 
 Samples were analyzed using Verogen’s ForenSeqTM Universal Analysis Software 
(UAS) version 1.3.6767 (Verogen, Inc., San Diego, CA) using the manufacturer set stutter 
filter percentages.  The analytical threshold was set at 1.5% of the total reads of a locus and 
the interpretation threshold was set at 4.5% of the total reads of a locus as recommended 
by the manufacturer.   
2.7 Contributor Ratio Determination 
 For both the CE and sequencer, contributor ratios of autosomal STRs were 
calculated using the RFU (for the CE) and the read count (for sequencing) of each allele at 
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loci chosen for analysis.  Loci were chosen for contributor ratio calculations only if they 
contained 3 or 4 alleles at a given locus as shown in Table 1, otherwise it would not have 
been possible to distinguish the major and minor alleles.  When 4 alleles were present at a 
locus, all 4 were used in calculating contributor ratios. However, in cases where a minor 
allele dropped out, the allele still present was doubled to replace the missing allele.  When 
only 3 alleles were present, it could mean both contributors are heterozygous and share one 
allele, or one contributor is homozygous and the other is heterozygous with no shared 
alleles.  In the first case, it was not possible to determine how much of the shared allele 
each individual contributed, so only the unshared alleles were used in the calculations.  In 
cases where both minor alleles dropped out of a 4-allele locus or the unshared minor allele 




Table 1.  Equations used for contributor ratio calculations of various autosomal STR combinations at an 
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 For each replicate, the mean contributor ratio over all the loci that fit the criteria 
described above was calculated.  For each run, the mean contributor ratio of each locus 
was calculated using the 4 replicates in that run and the mean contributor ratio over all 
replicated was calculated.  Then the mean contributor ratio was calculated for each locus 
and all replicates over both runs.  A standard deviation of each mean was also calculated 
and represented as error bars in the figures or reported with the mean.   
 The ForenSeqTM kit also includes SNPs in its primer set and the SNPs were 
looked at to determine if they could give a more accurate indication of mixture ratio than 
the autosomal STR loci.  SNPs do not have the same variability as STRs as they only 
look at a single base pair difference, and only one of two bases are seen at a specific 
locus.  For example, the rs735155 SNP can only have an A or G.  This makes any overlap 
between the two individuals impossible to distinguish the major and minor contributor.  
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Therefore, SNP loci were chosen only if both individuals were homozygous for the two 




3.  Results 
3.1 Sample Selection 
 DNA was isolated from 7 anonymous donors. The two individuals that were 
selected for two person mixtures were individual 434 and individual 438 because they 
were found to have 18 and 20 heterozygous loci out of the possible 21, respectively 
(Table 2).  This high level of heterozygosity also resulted in the overlap of 14 alleles, 
which might result in allele differences based on sequence.   
3.2 Capillary Electrophoresis 
 Each mixture was amplified in quadruplicate twice, over two different days for 
between run and within run variation.  In the first set of amplifications, however, one of 
the 1:4 mixtures did not amplify and resulted in only 3 replicates for this run.  It was 
found that 18 of the 21 autosomal STRs fit the criteria for contributor ratio calculations 
(as described in Section 2.7) and these loci (D1S1656, TPOX, D2S441, D2S1338, FGA, 
D5S818, CSF1PO, D7S820, D8S1179, vWA, D12S391, D13S317, D16S539, D18S51, 
D19S433, D21S11, D22S1045, and SE33) were used in the results that follow. 
3.2.1 1:1 Mixtures 
 The 1:1 mixture was prepared to be equal amounts of the 434 and 438 
contributors’ DNA based on the quantification results; therefore, the contributor ratio was 
expected to be approximately 1.  However, it was apparent in each run that 434 was 
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present at a higher concentration and was treated as the major contributor for all 
calculations of the 1:1 mixture.   
 The mean contributor ratio for amplifications 1-4 (n=72 loci) and amplifications 
5-8 (n=72 loci) were calculated to be 1.862 + 0.744 and 1.774 + 0.595, respectively.  
Overall, the mean contributor ratio for all 1:1 samples (n=144) came out to 1.818 + 
0.675.  Of the 18 loci the overall contributor ratio was consistent across all loci (Figure 
3).  A two-tailed t-test with an α-level of 0.05 was performed and it was found that there 
were no loci that were significantly different from the overall mean contributor ratio.  On 
top of consistency among loci, Figure 4 shows that there was high consistency of 
contributor ratios between replicates.  A t-test also confirmed that there was no 
significant difference among replicates. 
 
































Figure 4: Mean contributor ratio across replicates of 1:1 mixture samples run on the CE.  The blue bars represent 
those in amplification 1, the green bars represent those in amplification 2, and the orange line represents the mean 
contributor ratio of all replicates at 1:1. 
3.2.2 1:4 Mixtures 
  The mean contributor ratio for amplifications 1-3 (n=54) and amplifications 5-8 
(n=72) were found to be 8.040 + 5.649 and 7.483 + 3.030, respectively.  Overall, the 
mean contributor ratio for all samples (n = 126) was 7.722 + 4.359, while the expected 
ratio was 4.  Variability across loci appeared to be slightly increased in the 1:4 samples 
(Figure 5) compared to the 1:1 and D16S539 had an unusually high mean contributor 
ratio and an equally high variation when compared to other loci (12.833 + 11.054).  In the 
other direction, both D2S1338 (3.966 + 0.491) and D18S51 (4.918 + 1.158) performed 
very well when compared to the expected value of 4 for this mixture.  However, the 
contributor ratio of these two loci and D1S1656 was found to be significantly lower and 
higher than the mean contributor ratio, respectively.  Similar to the 1:1 samples, the 1:4 





























variation of replicate 1 is very apparent and likely caused by a very high ratio of 38.897 
at D16S539.  A box and whisker plot showed that this value was an outlier, and when 
removed, accounted for much of the variance (Figure 6).  Before removing the outlier, 
none of the replicates showed a difference from the mean but removing D16S539 caused 
replicate 1 to be significantly different.  A value of 25.103 at the vWA locus of replicate 
2 was also determined to be an outlier and updated in Figure 7.  Across all samples, 2 
allele dropouts occurred: one at D7S820 and one at SE33.  Both dropouts occurred during 
the second amplification and were at a four-allele locus which meant the contributor ratio 
was still able to be calculated. 
 





























Figure 6: Mean contributor ratio across replicates of 1:4 mixture samples run on the CE.  The blue bars represent 
those in amplification 1, the green bars represent those in amplification 2, and the orange line represents the mean 
contributor ratio of all replicates at 1:4. 
 
Figure 7: Mean contributor ratio across all replicates of 1:4 mixture samples minus D16S539 locus in replicate 1 
run on the CE.  The blue bars represent those in amplification 1, the green bars represent those in amplification 2, and 
the orange line represents the mean contributor ratio of all replicates at 1:4. 
3.2.3 1:9 Mixtures 
 Where the 1:4 samples only had two allele dropouts, the 1:9 samples had 18 allele 

























































values for all amplifications were very consistent, but the standard deviation was 
extremely high in all cases.  The mean for amplifications 1-4 (n=67) was 14.689 + 8.575, 
14.955 + 6.548 for amplifications 5-8 (n=70) and was 14.827 + 7.592 for the overall 
mean contributor ratio (n=137), almost double the expected ratio of 9.  This can be seen 
in Figure 8 by the large variance across all loci, most notably D13S317.  With the large 
amount of dispersion, 5 loci were found to be significantly different from the mean: 
D2S1338, D5S818, D12S391, D13S317, and D18S51.  When it came to reproducibility, 
the mean contributor ratios between runs were not significantly different from each other 
but replicate 3 was significantly different from the overall mean (Figure 9). 
 






























Figure 9: Mean contributor ratio across replicates of 1:9 mixture samples run on the CE.  The blue bars represent 
those in amplification 1, the green bars represent those in amplification 2, and the orange line represents the mean 
contributor ratio of all replicates at 1:9. 
3.3 MiSeq FGxTM 
 Using the ForenSeqTM Signature Prep Kit, each mixture was amplified in 
quadruplicate on two different days and sequenced on the Illumina MiSeqTM.  Of the 27 
autosomal loci amplified in the ForenSeqTM kit, 23 were determined to be suitable for 
contributor ratio calculations: D1S1656, TPOX, D2S441, D2S1338, D3S1358, D4S2408, 
FGA, D5S818, CSF1PO, D6S1043, D7S820, D8S1179, vWA, D12S391, D13S317, 
PentaE, D16S539, D18S51, D19S433, D20S482, D21S11, PentaD, D22S1045 (Table 3).  
The D22S1045 locus was consistently significantly higher in all mixture ratios and was 
not used for mean contributor ratio calculations.  These 23 loci included all the 18 used 





























amplifications resulted in a loss of a 1:1 and 1:4 replicate.  Of the 94 SNP loci, only 10 fit 
the criteria for contributor ratio calculations. 
 Of the 27 loci, 3 isoalleles were identified by sequence.  Individual 434 was a 
homozygous 17 at D3S1358 locus on the CE but was identified as being heterozygous 17 
since two alleles had a different sequence by one base (Figure 10) on the MiSeq FGxTM.  
At D13S317 locus, both individuals shared a 9 allele that was indistinguishable on the 
CE, but the MiSeq FGxTM revealed them to have a single base sequence difference 
(Figure 11).  The final isoallele occurred at the D21S11 locus, where the 30 allele shared 
by both individuals had 12 different bases spread out across the whole repeat sequence 
(Figure 12).  Additionally, there were 3 locations where the minor contributor was able to 
be distinguished from the major contributor’s stutter allele because of sequence 
differences.   
 
Figure 10: Genotype of individual 434’s D3S1358 locus illustrating the sequence difference of the isoalleles 
 
Figure 11: Individual 434’s 9 allele (top) and individual 438’s 9 allele (bottom) at the D13S3171 locus, 
illustrating their sequence differences 
 
Figure 12: Individual 438’s 30 allele (top) and individual 434’s 30 allele (bottom) at the D21S11 locus, 
illustrating their sequence differences 
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3.3.1 1:1 Mixtures 
 The overall autosomal STR mean contributor ratio (n=154) was calculated to be 
1.799 + 0.475 and the SNP mean contributor ratio (n=70) was 1.787 + 0.462.  There was 
little variation between amplifications, with mean value of run 1 (n= 66) equaling 1.780 + 
0.463 and run 2 (n=88) 1.814 + 0.484 for the STR loci and 1.760 + 0.422 and 1.807 + 
0.489 for the SNP loci for run 1 (n=30) and run 2 (n=40), respectively.  While the overall 
variation was low, the mean contributor ratio by locus was surprisingly variable (Figure 
13).  Of the 22 autosomal loci, 9 of the loci were calculated to be significantly different 
from the mean and 3 of the 10 SNP loci were significantly different from their mean 
(Figure 14).  However, between amplifications, none of the autosomal STRs (Figure 15) 
or the SNPs (Figure 16) showed a significant difference from the mean. 
 






























Figure 14: Mean contributor ratio of 1:1 mixture samples by SNP locus run on the MiSeq FGxTM.  
 
Figure 15: Mean contributor ratio of STRs across replicates of 1:1 mixture samples run on the MiSeq FGxTM.  
The blue bars represent those in amplification 1, the green bars represent those in amplification 2, and the orange line 






















































Figure 16: Mean contributor ratio of SNPs across replicates of 1:1 mixture samples run on the MiSeq FGxTM.  
The blue bars represent those in amplification 1, the green bars represent those in amplification 2, and the orange line 
represents the mean contributor ratio of all SNP replicates at 1:1. 
3.3.2 1:4 Mixtures 
 As with the CE, dropouts occurred at 1:4 ratio.  A total of eight STR alleles and 
one of the SNP alleles dropped out, but only one STR locus was unable to be recovered 
for contributor ratio calculations.  The variance increased greatly from the 1:1 samples, 
but it was lower than the CE variance at 1:4.  The overall mean contributor ratio (n=153) 
of the autosomal STRs was 7.452 + 3.515. The mean contributor ratio for the SNPs 
(n=69) was 8.726 + 3.473, which was significantly higher than the STRs.  Even though 
the variation increased, there was no difference in contributor ratio of the STR loci (7.783 
+ 3.612 and 7.452 + 3.515) or the SNP loci (9.235 + 4.202 and 8.334 + 2.721) between 
runs.  D3S1358, D6S1043, D12S391, and D18S51 were all around the expected ratio of 4 




























loci.  This could be explained by the minor contributor having an allele in stutter position 
at all these loci, but since the sequences of the stutter and minor alleles were the same, 
they could not be separated.  Figure 18 shows the consistency by replicate between each 
other and compared to the mean.  While the SNPs were significantly higher than the 
STRs, they were very consistent among themselves (Figure 19) and had only one locus 
that was significantly different (Figure 20).   
 
































Figure 18: Mean contributor ratio of STRs across replicates of 1:4 mixture samples run on the MiSeq FGxTM.  
The blue bars represent those in amplification 1, the green bars represent those in amplification 2, and the orange line 
represents the mean contributor ratio of all STR replicates at 1:4. 
 
Figure 19: Mean contributor ratio of SNPs across replicates of 1:4 mixture samples run on the MiSeq FGxTM.  
The blue bars represent those in amplification 1, the green bars represent those in amplification 2, and the orange line 


























































Figure 20: Mean contributor ratio of 1:4 mixture samples by SNP locus run on the MiSeq FGxTM.  
3.3.3 1:9 Mixtures 
 The 1:9 samples had many allele dropouts.  61 STR alleles and 2 SNP alleles 
dropped out resulting in the loss of 22 loci for contributor ratio calculations.  The overall 
(n=162) mean contributor ratio for the STRs was 13.524 + 6.063 and the SNPs (n=78) 
were significantly higher at 21.077 + 9.265.  Like the 1:4 mixtures, D3S1358, D6S1043, 
D12S391, and D18S51 were significantly lower than all other loci (Figure 21) and there 
were 4 other loci significantly different from the mean contributor ratio.  However, none 
of the replicates were significantly different (Figure 22).  This is also shown in the SNP 
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the STRs had high variability by locus, the SNPs had no significant difference between 
loci for 1:9 mixtures (Figure 24).   
 





























Figure 22: Mean contributor ratio of STRs across replicates of 1:9 mixture samples run on the MiSeq FGxTM.  
The blue bars represent those in amplification 1 and the green bars represent those in amplification 2, and the orange 
line represents the mean contributor ratio of all STR replicates at 1:9. 
 
Figure 23: Mean contributor ratio of SNPs across replicates of 1:9 mixture samples run on the MiSeq FGxTM.  
The blue bars represent those in amplification 1, the green bars represent those in amplification 2, and the orange line 

























































Figure 24: Mean contributor ratio of 1:9 mixture samples by SNP locus run on the MiSeq FGxTM 
3.4 CE Versus MiSeqTM 
 Figures 25 and 26 show a comparison of the 1:1 samples on the CE and MiSeqTM 
by locus and the overall mean contributor ratios, respectively.  The overall means were 
almost identical and the MiSeq FGxTM showed slightly less variance compared to the CE, 
although not significant (Table 2).  Only two loci showed a significant difference 
between the two analysis methods, D19S433 and D22S1045, both of which were higher 
on the MiSeqTM.  The two loci were also significantly higher on the MiSeq FGxTM at 1:4 
ratio as was D2S1338 (Figure 27); however, there was one locus, D12S391, that was 
significantly higher on the CE.  When it came to overall mean contributor ratio, neither 
the CE nor MiSeq FGxTM was different from the other at the 1:4 ratio (Figure 28).  Even 
at 1:9 ratio, the mean contributor ratio was consistent between the two methods, although 
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number of differences increased to 5 at 1:9 (Figure 30).  D22S1045 and D2S1338 were 
higher on the MiSeqTM than CE, but D18S51, D13317, and D12S391 were all higher on 
the CE.   
 


































Figure 26: Total mean contributor ratio of all 1:1 mixture samples on the CE versus MiSeq FGxTM 
 



























































Figure 28: Total mean contributor ratio of all 1:4 mixture samples on the CE versus MiSeq FGxTM 
 
























































Figure 30: Comparison of mean contributor ratio of STR loci of 1:9 mixture samples on the CE versus MiSeq 
FGxTM 
Table 2: Mean contributor ratios and their standard deviations compared on the CE and MiSeq FGxTM 
Analysis Method CE MiSeq FGxTM 
 Mean Standard Deviation Mean Standard Deviation 
1:1 1.818 0.675 1.799 0.475 
1:4 7.722 4.359 7.452 3.515 































4.  DISCUSSION 
NGS enables the sequencing of a large battery of forensic biomarkers including 
STR and SNP loci and could be the future of forensic DNA profiling.  The MiSeq FGxTM 
system is at the forefront of development and implementation of DNA sequencing in 
forensics and has been shown to be concordant with fragment-length CE analysis while 
overcoming some of the limitations of CE.  It has been demonstrated to meet the strict 
forensic validation guidelines set by SWGDAM to ensure the reproducibility and 
reliability of the system [4,31,32].  The data presented here demonstrates the 
reproducibility of the MiSeq FGxTM system and the benefits it can provide to mixture 
deconvolution.  The MiSeq FGxTM system produces an enormous amount of data and this 
study was only focused on the autosomal STRs and SNPs.  Additional X and Y-STRs 
could potentially be used to increase mixture resolution as more individualizing loci.   
The mixtures were prepared based on quantitation results using RT-PCR to be 
1:1, 1:4, and 1:9 at 0.2 ng/µL.  However, the fact that both the CE and MiSeqTM results 
were consistent across all replicates and concordant with each other indicate that the 
major contributor, 434, was double the expected quantitative value, thus resulting in 
higher ratios.  The concentrations determined by contributor ratios were found to be 
closer to 1:2, 1:8 and 1:14. 
A total of 1 ng input DNA was used for sequenced-based STR profiling of all 
samples, with the minor contributor at 0.5 ng, 0.2 ng, and 0.1 ng for 1:1, 1:4, and 1:9 
mixture ratios, respectively.  There have been numerous studies that showed full profiles 
can be generated at all of these ratios or amounts [28,32,33] using the MiSeq FGxTM 
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system; however, in this study full STR profiles could not be generated at 1:9 ratio and 
only two out of seven replicates at 1:4 ratio produced a full profile. The higher than 
expected concentration of the major contributor is also a likely factor in the poor allele 
coverage of the minor contributor.  Using the contributor ratio instead of the mixture 
ratio, it is reasonable to observe allele dropout at 1:4 (1:8 contributor ratio) and with no 
full profiles being generated at 1:9 (1:14 contributor ratio). In comparison, full profiles 
for five of the seven 1:4 mixtures (1:8 contributor ratio) and two of the eight 1:9 mixtures 
(1:14 contributor ratio) were generated on the CE platform. This is likely due to the less 
hands-on nature of the GlobalFilerTM amplification process. 
The MiSeq FGxTM performance was found to be concordant with that of the 
GlobalFilerTM-CE method in terms of contributor ratio.  However, there was a total of 68 
minor contributor alleles (9.09% of the total possible alleles) that were lost on the MiSeq 
FGxTM and only 20 on the CE (3.38% of the total possible alleles).  Most of those alleles 
lost on the MiSeq FGxTM (61 or 8.15%) and CE (18 or 3.03%) were from the 1:9 (1:14 
contributor ratio) mixture.  This difference may seem large, but there were an additional 5 
minor contributor alleles, per replicate, that could be identified by sequence. A total of 22 
samples were analyzed for an increase in 110 potential alleles that could be used, not 
including six additional loci present in the ForenSeqTM kit but not in the GlobalFilerTM 
kit. 
 MiSeq FGxTM appeared to perform worse in terms of variation in the mean 
contributor ratio on a per locus-basis.  For instance, high preferential amplification was 
observed at locus D22S1045 (see Section 3.4).  So much so that even the major 
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contributor lost an allele in one of the 1:9 mixtures.  The manufacturer mentioned this 
was possible and there have been other studies that report the same levels of preferential 
amplification at this locus [4].  Run by run and between replicates, however, the MiSeq 
FGxTM showed consistent contributor ratios and less variation in comparison to the CE.   
 The SNP loci are located on much shorter regions of DNA compared to STRs. At 
lower concentrations or in degraded DNA samples, shorter DNA strands are more likely 
to still be intact and be successfully amplified while longer DNA strands have a higher 
likelihood of being degraded and unable to be amplified.  The SNPs were analyzed here 
to determine if they present a more accurate representation of mixture ratio at lower 
concentrations.  Only 3 SNP alleles dropped out, one at 1:4 (1:8 contributor ratio) and 
two at 1:9 (1:14 contributor ratio); however, the contributor ratio values were 
significantly higher than STR loci and were therefore less reliable than the STRs.  
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5.  CONCLUSIONS 
 The MiSeq FGxTM system was developed specifically for the use in forensic DNA 
typing.  Since its release, there have been many studies evaluating its robustness, 
accuracy, and reproducibility.  The largest advantage next generation sequencing has 
over traditional CE methods is the ability to determine sequence variants in alleles when 
looking at mixture samples.  Between the two individuals sequenced in these mixtures, 
two minor contributor’s alleles could to be separated by sequence variation and three of 
them could be distinguished from the stutter peak of the major contributor.  In addition to 
the X- and Y-STRs and SNPs, the MiSeq FGxTM can provide a larger amount of 
information of mixture samples that cannot be obtained by the CE.   
 As the MiSeq FGxTM provides data in read counts and the CE in relative 
fluorescence units, the two cannot be directly compared to one another.  Instead, the ratio 
of the two contributors on each instrument was calculated for data comparison.  The data 
showed that the MiSeq FGxTM was concordant with the CE which should facilitate the 




Table 3: Table of GlobalFilerTM alleles of mixture contributors.  Loci that were used in contributor ratio 
calculations are marked with a 1.   
Locus 434 Alleles 438 Alleles 
D3S1358 17,17 16,17 
vWA1 16,19 14,17 
D16S5391 9,12 10,12 
CSF1PO1 10,11 11,12 
TPOX1 8,9 9,11 
Y-Indel 1 - 
Amelogenin X,Y X,X 
D8S11791 10,14 15,16 
D21S111 29,30 30,30.3 
D18S511 15,16 14,16 
DYS391 10 - 
D2S4411 10,11.3 11,14 
D19S4331 13,14 14,15.2 
TH01 9,9 8,9 
FGA1 22,25 23,25 
D22S10451 11,17 15,17 
D5S8181 7,12 11,12 
D13S3171 8,9 9,11 
D7S8201 11,11 12,13 
SE331 16,27.2 17,25.2 
D10S1248 13,15 13,13 
D1S16561 12,13 15,16 
D12S3911 20,22 15,15 









Table 4: Table of ForenSeqTM alleles of mixture contributors.  Where the individual is homozygous in allele length 
and sequence are listed as one number.  Where the individual has an allele of the same length but different sequence, 
the number is listed twice.  Loci that were used in contributor ratio calculations are marked with a 1 and alleles shared 
by the two individuals but with different sequences are marked with an asterisk.   
Locus 434 Allele 438 Allele 
Amelogenin X,Y X,X 
D1S16561 12,13 15,16 
TPOX1 8,9 9,11 
D2S4411 10,11.3 11,14 
D2S13381 19,24 19,23 
D3S13581 17,17 16,17 
D4S24081 8,10 9,10 
FGA1 22,25 23,25 
D5S8181 7,12 11,12 
CSF1PO1 10,11 11,12 
D6S10431 13,14 12,14 
D7S8201 11 12,13 
D8S11791 10,14 15,16 
D9S1122 12 12,13 
D10S1248 13,15 13 
TH01 9 8,9 
vWA1 16,19 14,17 
D12S3911 20,22 15,19 
D13S3171* 8,9 9,11 
PentaE1 5,20 10,14 
D16S5391 9,12 10,12 
D17S1301 12 11,12 
D18S511 15,16 14,16 
D19S4331 13,14 14,15.2 
D20S4821 13,14 10,16 
D21S111* 29,30 30,30.3 
PentaD1 11 10,12 
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